Company intelligence / Profile preview

Proteopure

Stony Brook, NY, USA

Ownership: Private
Development stage: Other

Overview

ProteoPure was a biotechnology company specializing in the development of advanced protein purification and proteomics tools. The company's primary focus was on its proprietary affinity purification technology, which allowed for the efficient isolation of recombinant proteins with high purity and yield. Their products were designed to streamline laboratory workflows for researchers in academia and the pharmaceutical industry. In 2006, ProteoPure was acquired by MP Biomedicals, which incorporated the company's purification kits and resins into its global life sciences catalog. The company originated as a spin-off from Stony Brook University and was based in New York.

Modalities: Recombinant proteinProtein purification
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Proteopure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteopure.

Explore the full profile